This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply and delivery of radiopharmaceutical kits. The contract has a ceiling value of $30,660.00 and a period of performance through June 2, 2025.
The radiopharmaceutical kits include Mebrofenin, Sulfur Colloid, Medronate, Sestamibi, Mertiatide, and Ultratag RBC, which are used in nuclear medicine imaging procedures. This award is not set aside for any specific business type.
Cardinal Health, a global healthcare services and products company, frequently receives federal contracts from agencies like the Department of Veterans Affairs (VA) and National Institutes of Health (NIH) for the supply of radiopharmaceuticals and other specialized medical products. The company has significant Indefinite Delivery Vehicle (IDV) contracts with the VA and NIH to support their nuclear medicine programs.
Generated 3/14/25, 9:47 AM